Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20170117032025N3Phase 3Completed
Phase 3, randomised, double-blind trial of lidocaine (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Pain severity. Started Mar 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20170117032025N3.